Intravenous Drug Usage Recruiting Phase 4 Trials for Elvitegravir (DB09101)

IndicationStatusPhase
DBCOND0055387 (Intravenous Drug Usage)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03549312Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyTreatment